Burning Rock Biotech Limited.
BNR.US | Research and experimental development on natural sciences and engineering
Burning Rock Biotech Limited, a biotechnology company, focuses on the development and commercialization of cancer therapy selection products in the People’s Republic of China. The company offers next-generation sequencing (NGS)-based therapy selection tests for various cancer types, including lung c...Show More
Better Health for All
40
Burning Rock Biotech's core business is the development and commercialization of cancer therapy selection products and multi-cancer early detection tests, which inherently provide transformative health benefits by enabling early diagnosis and personalized treatment. There is no evidence of revenue from products with negative health outcomes, indicating a complete transition to health-positive offerings. The company's R&D expenses were RMB49.2 million in Q3 2024, representing 38.26% of its total revenue of RMB128.6 million, demonstrating a significant investment in health innovation.
1
The company's multi-cancer early detection tests contribute to preventative health measures by enabling early diagnosis, with studies showing 65% of detected cancers were localized or regional.
2
Burning Rock Biotech conducts clinical trials, with one study for tumor gene mutation sequencing data analysis software having ethical committee approval from West China Hospital of Sichuan University in 2019.
3
This study also includes a plan for individual participant data sharing via www.chictr.org.cn, indicating strong data practices.
4
Fair Money & Economic Opportunity
0
No information regarding BNR.US or its operations relevant to the 'Fair Money & Economic Opportunity' value was found in the provided articles. The articles discuss LogicMark, Inc.
1
or were inaccessible,
2
providing no specific data points for BNR.US against any of the KPIs.
Fair Pay & Worker Respect
0
No specific, concrete data points were found across the provided articles for any of the KPIs under the 'Fair Pay & Worker Respect' value. Information regarding living wage coverage, CEO-to-median pay ratio, collective bargaining share, safety incident rate, pay equity ratio, worker engagement score, turnover rate, labor violation incidents, insecure contract share, or health insurance coverage for Burning Rock Biotech Limited was explicitly stated as missing or not available in the articles.
1
Fair Trade & Ethical Sourcing
0
No specific, concrete evidence was found in the provided articles for any of the KPIs related to Fair Trade & Ethical Sourcing for Burning Rock Biotech Limited.
1
The articles primarily focused on financial, regulatory, and internal conduct aspects, or were irrelevant to the company being assessed.
Honest & Fair Business
-10
The company has a Whistle Blowing Policy to establish procedures for employees and external parties to report misconducts.
1
Its consolidated financial statements for the year ended December 31, 2024, were audited by Deloitte Touche Tohmatsu, a Registered Public Interest Entity Auditor, indicating 100% coverage of the consolidated entity.
2
The company conducts training for employees to abide by anti-bribery and anti-corruption compliance requirements and applicable laws and regulations.
3
Kind to Animals
0
No evidence available to assess Burning Rock Biotech Limited on Kind to Animals.
No War, No Weapons
0
The provided articles discuss general U.S. export control policies, defense spending, and regulatory actions on certain dual-use laboratory instruments relevant to biotechnology and AI. However, none of the articles contain specific, concrete data points or actions related to Burning Rock Biotech Limited (BNR.US) concerning its revenue from arms contracts, involvement in dual-use technology development, sales to embargoed regimes, peacebuilding investments, or any other KPI under the 'No War, No Weapons' ethical value. Therefore, no KPIs can be scored based on the evidence provided.
Planet-Friendly Business
-30
The company has not been subject to any penalties from relevant authorities for failure to obtain or maintain required licenses or permits, nor for its business operations or clinical studies involving China HGR, as of the date of its annual report.
1
Additionally, no regulatory actions, violations, fines, or compliance issues were mentioned in Q1 2025 financial summaries.
2
Respect for Cultures & Communities
0
No specific, concrete data points were found in the provided articles for BNR.US regarding any of the KPIs related to 'Respect for Cultures & Communities'.
1
The articles either discuss general industry trends without company-specific data or explicitly state the absence of relevant information for BNR.US on these metrics.
Safe & Smart Tech
0
No evidence available to assess Burning Rock Biotech Limited on Safe & Smart Tech.
Zero Waste & Sustainable Products
0
The provided articles do not contain any specific, concrete data points related to waste diversion, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design principles, waste reduction initiatives, hazardous waste management, product durability, repairability, waste audit frequency, zero waste certification, waste disposal violations, material efficiency, packaging-to-product ratio, waste reduction targets, supplier waste requirements, or customer waste education.
1
All articles explicitly state a lack of data for these sustainability metrics.
2